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Abstract 
Bluetongue virus (BTV) replicates in lymphoid tissues where infected mononuclear leukocytes 
secrete proinflammatory and vasoactive mediators that can contribute to bluetongue (BT) 
pathogenesis. Using the well-characterized IFNAR(-/-) mice animal model, we have now studied 
the histopathology and dynamics of leukocyte populations in different target tissues (spleen, 
thymus, and lung) during BTV-4 infection by histological and immunohistochemical techniques. The 
spleen and thymus of BTV-4 infected mice showed severe lymphoid depletion on H&E stained 
sections. This finding was confirmed by IHC, showing moderate decreased immunopositivity 
against CD3 in the thymus, and scarce immunoreactivity against CD3 and CD79 in the rest of the 
white pulp in the spleen, together with an increase in MAC387 immunostaining. BTV-4 infection 
also induced the expression of active caspase-3 in the spleen, where apoptotic debris was 
observed by H&E. A dramatic increase in iNOS immunoreactivity associated to necrotic areas of 
the white pulp was observed, being less noticeable in the thymus and the lung. The induction of 
pro-inflammatory cytokines in tissues where BTV replicates was evaluated by measuring transcript 
levels by RT-qPCR. BTV-4 infection led to enhance transcription of IFN-γ, TNF, IL-6, IL-12-p40, 
and IL-1β mRNA in the thymus, spleen and lung, correlating with the level of virus replication in 
these tissues. Disease progression and pathogenesis in IFNAR(-/-) mice closely mimics hallmarks of 
bluetongue disease in ruminants. IFNAR(-/-) mice are a good choice to facilitate a faster advance in 
the field of orbiviruses. 
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Introduction 
Bluetongue virus (BTV) causes bluetongue, a 
major hemorrhagic disease of ruminants. The virus, 
consisting of 27 different serotypes [1-3], is 
transmitted to its vertebrate host by a few species of 
biting midges of the Culicoides genus (Diptera: 
Ceratopogonidae) [4]. Natural BTV infection of 
ruminants begins with intra-dermal introduction of 
the virus during the blood feeding of an infected 
insect. The inoculated virus first infects mononuclear 
inflammatory cells, including dendritic cells, and it 
then drains to the local lymph node where further 
replication occurs prior to the infected cells migrating 
to the tissues that have been described as the 
secondary sites of BTV replication such as the lungs, 
spleen, thymus, and lymph nodes [5-9]. 
Virus replication in mononuclear phagocytic, 
dendritic, and endothelial cells (ECs) and the response 
of these cells to the infection are critical in the 
pathogenesis of BTV [8, 10-12]. The inflammatory and 
vasoactive mediators released by BTV-infected 
ruminants have been proposed as responsible of the 
increased vascular permeability that characterizes 
severe BT; specifically, vasoactive mediators released 
from BTV-infected cells exert paracrine effects that 
increase the permeability of adjacent blood vessels 









pro-inflammatory cytokines such as IL-12, IFN-γ, IL-8, 
and TNF, as well as vasoactive mediators produced in 
monocytes/macrophages and cytotoxic lymphocytes 
(CTLs) are likely involved in BTV pathogenesis and 
viral kinetics [14]. Thus, the endothelial injury 
observed during BTV infection could be due to the 
direct pathogenic effect of BTV infection on 
endothelial cells or to a response to inflammatory 
mediators released by virus-infected cells. Similarly, 
production of pro-inflammatory cytokines by 
macrophages has been shown to contribute to the 
pathogenesis of human viral hemorrhagic fevers 
[15-17]. 
To date, few in vivo studies have been carried out 
to clarify the source and the role of pro-inflammatory 
cytokines in the appearance of lesions during BTV 
infection using tissue samples from naturally or 
experimentally infected ruminants [18]. Because BTV 
natural hosts are expensive and require specialized 
animal facilities with biosafety level 3, the IFNAR(-/-) 
mouse is a good model to study many aspects of 
pathogenesis, virulence, vaccine efficacy and immune 
response to BTV [19-26]. In this animal model, we can 
closely follow infection and disease progression in a 
short period of time. 
The main objective of this work was to study in 
the IFNAR(-/-) mice model several pathological 
aspects reported in BTV infected ruminants. The 
histopathology and dynamics of monocytes/ 
macrophages, and B and T lymphocytes of infected 
mice were analyzed by means of histopathological 
and immunohistochemical methods on tissue samples 
from IFNAR(-/-) mice experimentally infected with 
BTV-4. Moreover, the presence of inducible nitric 
oxide synthase (iNOS), that modulates adaptive 
immune responses, and active caspase-3, an indicator 
of apoptosis, were also analyzed in these tissues by 
immunohistochemistry. This study was completed 
with the experimental analysis of the induction of 
expression of pro-inflammatory cytokines (IL-1β, 
IL-12, IFN-γ, IL-6, and TNF) in the infected tissues to 
better understand the pathology of BTV.  
Materials and Methods 
Virus and cells  
KC cells, obtained from C. sonorensis larvae, were 
grown in Schneider's insect medium supplemented 
with 10% FBS. BTV serotype 4 (MOR2009/09) 
(BTV-4(M)), isolated from sheep blood in KC insect 
cells [27], was used in the experiments. KC cells and 
BTV-4(M) were generously provided by Professor 
Peter Mertens (The Pirbright Institute, UK).  
Mice 
IFN α/βRo/o IFNAR(-/-) 129/Sv mice and wild 
type 129/Sv mice were purchased from B&K 
Universal Ltd UK. Eight-week old male mice were 
used throughout the study. Mice were maintained 
under pathogen-free conditions and allowed to 
acclimatize to the biosafety level 3 (BSL3) animal 
facility at the Centro de Investigación en Sanidad 
Animal, INIA, Madrid, for 1 week before use. All 
experiments with live animals were performed under 
the guidelines of the European Community (86/609) 
and were approved by the ethical review committee 
at the Centro de Investigación en Sanidad Animal of 
the Instituto Nacional de Investigaciones Agrarias 
(Permit number: CEEA 2010-034) . All efforts were 
made to minimize suffering as well as the number of 
animals employed. 
Animal inoculation and processing of samples  
Mice were infected subcutaneously with 
different doses of virus. Mice were examined for 
clinical signs daily. Whole blood was collected in 
EDTA from all animals at regular intervals after 
inoculation. At varying times post-infection, several 
mice were sacrificed, perfused with 
phosphate-buffered saline (PBS), and several organs 
(spleen, lung, and thymus, and lymph nodes) were 
harvested. Tissues were homogenized in PBS using a 
Tissue Lyser homogenizer (Qiagen). The viruses were 
released from whole blood and homogenized tissues 
by three freeze/thaw cycles. The amount of infectious 
virus was measured by real-time RT-qPCR specific for 
BTV segment 5 as described by Toussaint et al. (2007). 
Blood measurements 
A multiparameter, Autohematology Analyzer 
(BC-5300 Vet, Mindray, China) was used to determine 
the total and differential cell counts in blood collected 
into EDTA tubes.  
Histopathology and immunohistochemistry  
Samples from different tissues and organs 
(spleen, lung, and thymus) were fixed in 10% buffered 
formalin (pH 7.2) for histopathological studies. After 
fixation, samples were dehydrated through a graded 
series of alcohol to xylol and embedded in paraffin 
wax. Sections of 4 µm thick from paraffin wax blocks 
were cut and stained with hematoxylin and eosin (H 
& E) for histopathological analyses. 
For immunohistochemical procedures, 3 µm 
thick sections were mounted on slides coated with 
silane and dried at room temperature (RT) for 24 h. 
Unless otherwise stated, all incubations were 
performed at RT in a humid chamber and the slides 
were washed three times for 5 min in 0.1 M PBS 





containing 0.05% Tween-20 (Sigma-Aldrich) after 
each incubation. The endogenous peroxidase activity 
was inhibited by incubating sections with peroxidase 
blocking reagent (Dako, Denmark) for 1 h. The 
primary antibodies and immunohistochemical 
procedures are listed in Table 1. After incubation with 
the primary antisera, sections were incubated for 30 
min with the secondary antibody, either anti-rabbit or 
mouse En Vision+ System Labelled Polymer-HRP 
(Dako). Peroxidase reaction was developed using 
3.3′diaminobenzidine tetrahydrochloride as 
chromogen diluted 1:50 in a specific buffer (Dako, 
Denmark). Finally, sections were counterstained with 
hematoxylin, dehydrated and coverslipped with 
DePex mounting medium. Negative controls were 
obtained substituting the primary antibody by an 
irrelevant antibody or by PBS. Suitable tissues from 
other species were employed as positive controls. 
Total RNA extraction and first-strand cDNA 
preparation 
Spleen, lung and thymus were collected from 
each mouse and stored in RNAlater® (Ambion, USA) 
at −80 ºC before use. Organs were homogenized in 
Trizol® reagent (Life Technologies, USA) using a 
Tissue Lyzer homogenizer (Qiagen) following the 
manufacturer´s protocol. Briefly, after Trizol reagent 
addition and homogenization, chloroform was added. 
The sample was centrifuged and the aqueous phase 
was recovered. RNA was precipitated from the 
aqueous phase with 2-propanol, washed with 75% 
ethanol, and resuspended in sterile water. RNA 
concentration and purity were estimated 
spectrophotometrically based on absorbance at 260 
and 280 nm. First-strand cDNA was synthesized from 
0.5 μg of total RNA, which was reversely transcribed 
by using superscript III reverse transcriptase (Life 
Technologies, USA) and oligo (dT) as a primer. 
Analysis of cytokine gene expression and 
transcriptional regulation 
In order to monitor pro-inflammatory cytokines 
(IL 1-β, IL 6, IL 12p40, IFNγ and TNF) transcript levels 
in organs (spleen, lung and thymus) of IFNAR(-/-) 
mice infected with a lethal dose of BTV-4 were 
quantified by RT-qPCR (ECO™ Real-Time PCR 
System, Illumina®, San Diego, California, U.S.). PCR 
experiments were carried out using the first-strand 
cDNAs as templates with specific primer pairs 
(Table 2). Target gene copy numbers were normalized 
using actin gene as a control, also amplified by 
RT-PCR. RT-qPCR was performed on an Illumina® 
ECO™ thermal cycler (San Diego, California, U.S.), 
using SsoFast™ EvaGreen® Supermix (Bio-RadINK, 
Hercules, California, US) in 10-μL reaction volumes 
comprising 1 μL of cDNA template, 5 μL of 2x 
SsoFast™ mixture (with EvaGreen Dye), 1 μL of 
primer mix (5 μM/each), and 3 μL ddH2O. PCR 
conditions were as follows: initial denaturation at 
95°C for 30 s followed by 40 cycles of 95°C for 5 s, 
60°C for 10 s and 60ºC for 10 s. After PCR, a melting 
curve analysis was performed by increasing the 
temperature from 60ºC to 95ºC, with a temperature 
transition of 0.5ºC/s. Each gene sample was run in 
duplicate for both infected and negative controls. No 
template controls were used in all analyses. The 
software used to analyze the data was EcoStudy®. A 
dissociation curve was generated for each sample 
after completion of amplification and analyzed 
compared with the negative controls. The 
comparative CT (2-ΔΔCT) method was used to analyze 
variations in gene expression in terms of relative fold 
differences between the experimental (BTV infected) 
and calibrator (un-infected control) samples [28]. For 
relative quantification, the amount of target was 
normalized to an endogenous reference (actin, 
housekeeping gene) and the calibrator 2-ΔΔCT formula 
was used: where ΔΔCT= ΔCT (sample) - ΔCT 
(calibrator), the CT value indicated fractional cycle 
number at which the amount of amplified target 
reached the fixed threshold, and ΔCT represented CT 
of the target gene subtracted from CT of the 
housekeeping gene. The mean CT values of duplicate 
samples of test and control mice were used for 
analysis. Results were presented as means ± standard 
error (SE) of data from duplicate replicates. 
Table 1. Primary antibodies and immunohistochemical procedures used in the histopathological studies. 
Primary antibody Type Antigen retrieval method Working dilution Incubation parameters 
CD3 (IS503, Dako) Rabbit polyclonal Heating under pressure in 10 mM Tris-EDTA buffer 
(pH 9), 15 min 
1:600 2 h at RT 
iNOS (AHP477, Serotec) Rabbit polyclonal None 1:3000 2 h at RT 
MAC387 (MS-148-R7, Neomarkers) Mouse monoclonal Proteinase K, 1:500 / 15 min RTU 2 h at RT 
Active Caspase-3 (G7481, Promega) Rabbit polyclonal Heating under pressure in 1 mM EDTA buffer (pH 8), 
2 min 
1:500 2 h at RT 
CD79α (IR621, Dako) Mouse monoclonal Heating under pressure in target retrieval solution 
high pH (Dako), 15 min 
RTU 2 h at RT 
 
 





Table 2. Primers used to analyze cytokine gene expression by RT-qPCR. 












Actin  GACGATGCTCCCCGGGCTGTATTC (24) TCTCTTGCTCTGGGCCTCGTCACC (24) 117 60 5  87 
IL-1-β CAACCAACAAGTGATATTCTCCATG (25) GATCCACACTCTCCAGCTGCA (21) 152 60 5  83 
IL-6 ACCACGGCCTTCCCTACTTCAC (22) TCCTCATTTCCACGATTTCCCAG (23) 134 60 5  81 
IL-12p40 ACAGCACCAGCTTCTTCATCA (21) TCTTCAAAGGCTTCATCTGCA (21) 75 60 5  82 
IFNγ GCGTCATTGAATCACACC (18) GGACCTGTGGGTTGTTGACC (20) 105 60 5  81 
TNFα AGCCCACGTCGTAGCAAACCAC (22) ATCGGCTGGCACCACTAGTTGGT (23) 121 60 5  88 
 
Results 
Susceptibility of IFNAR(-/-) mice to BTV-4 
Morocco strain  
To determine the susceptibility of IFNAR(-/-) 
mice to BTV-4(M), animals were inoculated 
subcutaneously with ten-fold serial dilutions of 
BTV-4(M). At a low infection dose (102 pfu/mice) 
IFNAR(-/-) mice were susceptible to BTV-4(M) 
infection, showing disease clinical signs characterized 
by ruffled hair, ocular discharges, reduced activity, 
and apathy starting at 48 h.p.i. Disease progression 
led to animal death and 100% of the infected animals 
died at 5 d.p.i. Similar results were observed with a 
dose of 103 pfu/mice. Higher infection dose of 104 
pfu/mice killed 100% of the animals at 72 h.p.i. and 







Figure 1. Susceptibility of adult mice to BTV-4 Morocco strain infection. 
IFNAR(-/-) mice (8 weeks old, 5 mice per group) were subcutaneously inoculated 
with 10-fold dilutions of BTV-4. The number of PFUs inoculated is indicated on each 




Blood parameters and viraemia in BTV 
infected IFNAR(-/-) mice. 
Viral spread and viraemia were determined in 
blood and tissue samples of mice infected with 103 
pfu/mice by RT-qPCR. Viraemia was detected at 24 
h.p.i and the presence of virus in blood was increased 
thereafter until animal death. The first tissue to be 
reached by the virus was the spleen where BTV 
genome was detected as early as 24 h.p.i. (Ct: 
30.49±1.05) (Table 3). By 48 h.p.i. viral genomes and 
BTV protein (figure S1) were also detected in the lung, 
thymus, and inguinal lymph nodes. The presence of 
BTV genomes increased thereafter until the death of 
the animal. No infectious virus was detected in the 
liver, brain, heart, tongue, skin, and testicles at any 
time points examined (data not shown).  
Changes in haematology were determined after 
infection of IFNAR(-/-) mice with 103 pfu/mice (Fig. 
2). BTV infection resulted in a significant decrease in 
the total white blood cell counts by 72 h.p.i (from 
9.6x106 to 2.54 x106 cells/ml) highlighted by a 8-fold 
drop in the absolute lymphocyte counts as well as a 
60% reduction in the percentage of lymphocytes. In 
addition, a dramatic reduction in the absolute 
monocyte count was detected in the infected mice. In 
contrast, an increase in the neutrophil percentage and 
in their absolute count was observed due to the BTV 
infection. Platelet counts also decreased in 
BTV-infected mice by up to 2-fold over the course of 
the infection. Thrombocytopenia is indicative of 
coagulation disorders and may partially explain the 
haemorrhages observed in the spleen, lung and liver 
of BTV infected mice (figure S2). 
 
Table 3. Detection of BTV-4(M) in blood and tissues of infected 
IFNAR(-/-) mice after challenge by RT-qPCR_S5.  
 24 h.p.i.  48 h.p.i.  72 h.p.i.  
Blood  29.07±1.02  25.05±0.23  23.78±1.1  
Thymus  Neg. 29.17±21.54 21.71±0.92 
Lung  36.69±1.23  22.84±1.1  20.77±3.31  
Spleen  30.49±1.05  22.88±2.32  18.89±1.37  
Lymph node (inguinal) N.D.  25.82±1.25  22.37±2.64  
Results expressed as Ct and transferred to negative (neg.) according to the cut-off 
Ct≥38 described by Toussaint et al. (2007).  
 






Figure 2. Blood parameters in IFNAR(-/-) mice infected with BTV-4 Morocco strain. Mice were infected subcutaneously with 103 PFU of BTV-4 (MOR2009/09) per 
mouse. Whole blood was collected at 72 h.p.i. and the following parameters were analyzed: lymphocytes, monocytes, neutrophils, basophils, eosinophils, and platelets. (A), Cell 
count. (B), Cell percentage. The results represent the average of 5 mice ± SD. Asterisks represent significant difference between samples, calculated by Man-Whitney non 
parametric test (p≤0.01). 
 
Histopathologic changes in organs of BTV 
infected IFNAR(-/-) mice 
In order to study the pathological effects of the 
infection in the organs where BTV-4 replicates, 
histological analysis were performed on several 
organs extracted from BTV infected and uninfected 
IFNAR(-/-) mice at 72 h.p.i. Light microscopy on 
lungs from infected mice revealed diffuse interstitial 
pneumonia characterized by hyperaemia, thickening 
of alveolar septa with infiltrates composed by 
mononuclear cells and scarce neutrophils, and the 
presence of oedema and leak of red blood cells into 
the alveolar spaces (Fig. 3). The spleen of infected 
mice showed severe white pulp lymphocytolisis and 
lymphoid depletion, as well as neutrophilic infiltrates 
in the margin between the red and white pulp (Fig. 3). 
As splenic lesions progressed, the white pulp was 
reduced to small foci of periarteriolar lymphoid 
tissue, surrounded by abundant apoptotic debris, 
neutrophils and siderocytes (Fig. 3). Lymphoid 
depletion was also observed in the thymus, where the 
typical structure of medulla-cortex was 





indistinguishable and large areas of the parenchyma 
were replaced by necrotic tissue (Fig.3).  
By means of immunohistochemistry, a 
dramatically decrease of immunoreactivity against 
CD3 antibody (a T cell marker) was observed in the 
spleen and thymus of the infected mice, with foci of 
CD3+ cells in periarteriolar areas of the spleen and 
few positive cells scattered through the thymus 
parenchyma (Fig. 4). Similarly, a lower number of 
cells immunoreactive against CD79 (a B cell marker), 
restricted to the remnants of the white pulp, was 
observed in the spleen from infected mice compared 
to control. Besides, scarce small foci of CD79+ cells 
were found in the lungs, close to pneumonic areas 
(Fig. 5). On the other hand, a clear increase in 
immunoreactivity against MAC387 and iNOS 
antibodies was detected in the spleen and thymus of 
the infected mice. Positive cells to both antibodies 
were diffusely observed in the thymus parenchyma, 
whereas in the spleen, MAC387+ cells were mainly 
located in the remaining white pulp (Fig. 6) and 
iNOS+ cells were not only associated with the white 
pulp, but also scattered throughout the necrotic areas 
(Fig. 7). A few number of immunopositive cells 
against iNOS and MAC387 antibodies were also 
observed in the mononuclear inflammatory infiltrates 
in the lung of BTV-infected animals. The morphology 
of cells positive to MAC387 antibody was compatible 
with either monocytes/macrophages, whereas iNOS+ 
cells were compatible with both monocytes/ 
macrophages and neutrophils. Furthermore, BTV-4 
infection also induced a higher expression of active 
caspase-3 in the spleen and thymus from 
BTV-infected mice compared to control animals, 
concurring with the apoptotic debris observed by 
H&E (Fig. 8). In the remaining organs evaluated, no 
significant changes were observed between control 
and infected mice for neither the number nor the 
distribution of cells immunoreactive against the 
antibodies employed in this study. 
 
Figure 3. Comparative photomicrograph of tissue sections from BTV-4- infected and control animals. H&E, 100X. IFNAR(-/-) mice (n = 3) were infected 
subcutaneosuly with 103 PFU of BTV-4. Representative pictures of tissues from the spleen, thymus, and lung collected at 72 h.p.i. and stained with hematoxylin and eosin, are 
shown. Extensive necrosis and lymphoid depletion, mainly located in the marginal zone bordering the white pulp (asterisk), was detected in the spleen from BTV-infected 
specimens, as well as a population of neutrophils and macrophages invading necrotic tissue. The thymus of BTV-infected animals showed extensive necrosis and lymphoid 
depletion (asterisk), with loss of the boundaries between the medulla (M) and the cortex (C). In the lungs of BTV-infected animals a diffuse interstitial pneumonia was 
encountered, showing multifocal atelectasis and increased septum size (arrows), with infiltration of mononuclear cells and scarce neutrophils. 






Figure 4. Representative photomicrographs showing the difference in the number/distribution of CD3 positive cells in spleen, thymus and lung, between 
BTV-infected and Mock mice. IHC against CD3, 100X. A significant decrease in the number of CD3+ cells was observed in spleen and thymus from infected animals. 
Populations of CD3+ cell were restricted to periarteriolar areas in spleen (asterisk). A mild increase in the number of CD3+ cells, dispersed throughout the pulmonary 
parenchyma, was also observed.  
 
Figure 5. Representative photomicrographs of immunohistochemical technique against CD79 antibody in spleen and lungs from BTV-4-infected and 
Mock animals. IHC against CD79 antibody, 100X. Immunoreactivity against CD79 was mainly present close to the remnants of the white pulp in the spleen of infected 
mice, being diminished in BTV-infected mice compared to controls. A small cluster of CD79+ cells (arrow) was observed in lungs of BTV-infected animal, within a pneumonic 
focus. 






Figure 6. Representative micrographs of immunohistochemical technique against MAC387 antibody in spleen, thymus and lungs from BTV-4-infected 
and Mock animals. IHC against MAC387 antibody, 100X. Positivity against MAC387 antibody in Mock-infected mice was mainly found in medullar sinuses (arrow), 
whereas in infected individuals the number of MAC387+ cells was increased, being scattered throughout the white pulp (asterisk). Immunoreactivity against MAC387 antibody 
was higher in the thymus from BTV-4-infected mice when compared with control animals, mainly in peripheral areas of the thymic parenchyma. Few small foci of MAC387+ cells 
(arrow) present in lung of BTV-infected animal, close to a bronchiole. 
 
BTV infection causes strong proinflammatory 
immune responses in IFNAR(-/-) mice 
To further investigate the pathogenesis of BTV, 
we evaluated the induction of pro-inflammatory 
cytokines in the tissues where BTV replicates by 
measuring transcript levels. IFNAR(-/-) mice 
developed strong pro-inflammatory immune 
responses following BTV-4 infection, as demonstrated 
by a significant increase in mRNA of IL-1β, IL-6, 
IL-12p40, IFN-γ, and TNF in the lung, and specially in 
the thymus and spleen (Fig. 9). The upregulation of 
pro-inflammatory cytokine mRNA correlated with 
virus replication, iNOS induction and the presence of 
monocytes/macrophages in these tissues. 
Discussion 
Ruminants are the natural host species in which 
BT disease occurs and are therefore the preferred 
animals to conduct experimental infection studies. 
However, infection studies using ruminants are 
expensive and time consuming and a limited number 
of animals are generally included [29]. Inbred 
IFNAR(-/-) mice are far easier and cheaper to work 
with. A tremendous advantage of this mouse model is 
the availability of a wide variety of reagents that can 
be used to study many aspects of the immune 
response to the virus. Although extrapolation of 
findings in mice to ruminants must be done with care 
due to differences in the biology between mouse and 
ruminant species, IFNAR(-/-) mice have been used as 
an animal model to study BTV transmission, 
pathogenesis, virulence, and protective efficacy of 
inactivated and new recombinant marker BTV 
vaccines [19-26]. 
The susceptibility of IFNAR(-/-) mice to BTV 
infection has been previously characterized in our 
laboratory for strains of BTV-1, BTV-8, and BTV-4 [20, 
30, 31]. For the present work we have used a strain of 
BTV-4 (MOR2009/09) isolated from sheep blood by 





using a culicoides cell line (KC cells) that has not been 
passed through mammalian cell lines. The clinical 
disease produced in IFNAR(-/-) mice infected with 
BTV-4(M) includes high viraemia and viral tissue 
titers in spleen, lung and thymus, which were 
detectable starting at 2 d.p.i. until death. Thus, an 
increased percentage of neutrophils and profound 
loss of lymphocytes, monocytes and platelets was 
observed in the blood after BTV infection. These 
results reproduce the data reported in experimental 
infections of sheep with BTV-23 and white-tailed deer 
with BTV-17 where marked thrombocytopenia, 
lymphopenia, and neutrophilia were observed [13, 32, 
33]. Lymphoid depletion and neutrophilic infiltrates 
were observed in H&E stained sections of spleen and 
thymus of BTV-4(M) infected IFNAR(-/-) mice. 
Lymphoid depletion was confirmed by IHC, showing 
moderate decreased immunopositivity against CD3 in 
the thymus, and scarce immunoreactivity against CD3 
and CD79 in the remains of the white pulp of the 
spleen. The reduction in CD3 and CD79 reactivity in 
lymphoid tissues of BTV infected mice indicates 
lymphopenia, as it has been described commonly in 
sheep during infections with several BTV serotypes. 
One of the mechanisms proposed for lymphoid 
depletion includes apoptosis [34]. Alternatively, BTV 
replication in lymphocytes, monocytes/macrophages 
and/or dendritic cells could result in cellular injury 
[35]. Lymphoid depletion could produce 
immunosupression and predisposition to secondary 
microbial infections as it has been observed in 
experimental infections of sheep with BTV. A positive 
signal specific of BTV has been observed in the lymph 
nodes, spleen, and thymus of BTV infected mice [31]. 
In addition, a clear increase of active caspase-3 was 
detected in the same tissues after infection indicating 
that both mechanisms can be also implicated in the 
lymphoid depletion observed in IFNAR(-/-) mice.  
 
 
Figure 7. Representative micrographs of immunohistochemical technique against iNOS antibody in spleen, thymus and lungs from BTV-4-infected and 
Mock animals. IHC against iNOS antibody, 100X. The number of iNOS+ cells was highly increased in spleen from BTV-infected animals and these cells were mainly 
located in necrotic areas surrounding the white pulp (asterisk). In the thymus of infected mice, immunoreactivity against iNOS antibody was higher than mock-infected individuals 
and was randomly distributed throughout the parenchyma. A few number of iNOS+ cells was present in the inflammatory infiltrate of the lung of infected mice. 






Figure 8. Representative micrographs of immunohistochemical technique against active caspase-3 antibody in spleen, thymus and lung from 
BTV-4-infected and Mock animals. IHC against caspase-3 antibody, 100X. The number of active caspase-3 cells was moderately increased in spleen, thymus, and lung 
from BTV-infected animals, concurring with the apoptotic debris. 
 
In contrast, an increase in MAC387 
immunostaining was observed mainly in spleen and 
thymus and, to a lesser extent, in lung of infected 
mice. The morphology of cells positive to MAC387 
antibody was compatible with either 
monocytes/macrophages. The accumulation of 
macrophages in these three tissues has been 
previously reported in BTV infected ruminants [9, 36] 
and it has been suggested that macrophages are 
positioned in the infected tissues to capture, 
internalize and process BTV antigens.  
Previously it was reported from both in vivo and 
in vitro studies that BTV- infected mononuclear 
leukocytes (dendritic cells, macrophages, monocytes 
and some lymphocytes) secrete numerous 
pro-inflammatory cytokines, including IFN-α, IFN-γ, 
IL-12, TNF, IL-1β and IL-8 [8, 14, 37-39]. Induction of a 
balanced antiviral and pro-inflammatory response is 
crucial to control viral replication and activate optimal 
adaptive immune responses. Although such response 
is required for viral clearance, depending on the type 
of disease, it may also damage tissues in severe cases, 
contributing to disease pathogenesis [40]. The 
endothelial injury observed in ruminants during BTV 
infection could be due to the direct pathogenic effect 
of BTV infection on endothelial cells or to a response 
to inflammatory mediators released by virus-infected 
endothelial cells and, possibly, other cell types such as 
monocytes/macrophages [8, 14, 18, 39]. Furthermore, 
in vitro BTV infections of peripheral blood 
mononuclear cells (PBMC) from a number of 
ruminant species resulted in the production of 
inflammatory cytokines. BTV infection of PBMC from 
bovine [39], sheep and goats [41] induced IL-1, 6, 8, 
and 10, IFN-γ, TNF and iNOS, although these studies 
used different experimental designs and BTV 
serotypes, making correlations among species 
difficult. 






Figure 9. Proinflammatory cytokines changes in IFNAR(-/-) mice infected with BTV-4 Morocco strain. Tissue samples were collected at the indicated time points 
from individual IFNAR(-/-) mice (3 per time point) infected with 103 PFU of BTV-4. Total RNA from spleen, thymus and lungs were extracted, and the expression of mRNA of 
proinflammatory cytokines was quantified. The expression levels of the different genes were normalized to levels in mock-infected mice. Columns represent mean values and 
error bars represent the SD of three independent mice per group. 
 
To further investigate whether the presence of 
macrophages in spleen, thymus, and lung of BTV 
infected IFNAR(-/-) mice correlated with an 
activation of pro-inflammatory response in these 
tissues we evaluated the induction of 
pro-inflammatory cytokines in the tissues where BTV 
replicates by measuring transcript levels. BTV 
infection of IFNAR(-/-) mice resulted in increased 
transcription of genes encoding IL-1β, IL-6, IL-12p40, 
IFN-γ, and TNF. In addition, the higher presence of 





macrophages in spleen and thymus correlated with 
higher induction of pro-inflammatory cytokines, 
tissues, which also showed higher histopathological 
alterations. Besides the induction of pro-inflammatory 
cytokines observed in serum and tissues of BTV 
infected ruminants, it has been also reported that BTV 
infection of sheep led to enhance transcription of 
iNOS in peripheral blood mononuclear cells and 
regional lymphoid organs [42]. Furthermore, in vitro 
studies provided evidence that cytokines and other 
vasoactive substances produced in macrophages 
potentially contributed to vascular injury in 
BTV-infected ruminants [39]. The IFNAR(-/-) mouse 
model reproduced in vivo the increase expression of 
iNOS in BTV-4(M) infected tissues. Positive cells to 
iNOS antibody were slightly augmented in lung and 
greatly increased in spleen and thymus of infected 
animals, compared to the control mice, and the 
morphology of cells positive to iNOS+ were 
compatible with both monocytes/macrophages and 
neutrophils. Nitric oxide is a potent anti-viral 
molecule to combat infection in combination with 
acute phase proteins and cytokines. Nevertheless, the 
excessive production of iNOS, and subsequent high 
levels of NO during viral infections may have 
negative effects, acting with other damaging oxidants 
to promote excessive inflammation or induce 
apoptosis, as it has been described in influenza virus 
infection [43]. As it has been described in the 
pathogenesis of viral hemorrhagic fevers [15, 44, 45], 
the overproduction of iNOS and pro-inflammatory 
cytokines in BTV infected tissues could contribute to 
the pathology of this disease-causing vasodilatation, 
increase of leukocyte adhesion and thrombus 
formation, and increase of vascular permeability of 
endothelial cells with subsequent tissue edema [39, 
46].  
BTV induces apoptosis both in cultured cells and 
in target tissues in vivo and one current hypothesis is 
that apoptosis plays a major role in the pathogenesis 
of BTV infection [47-49]. The spleen of BTV infected 
IFNAR(-/-) mice showed apoptotic debris and high 
presence of active caspase-3, reproducing the 
apoptotic effect observed in BTV infected sheep. 
Active-caspase-3 is an important pro-apoptotic 
molecule and acts as final effector in all apoptotic 
pathways, and it can be considered as a good marker 
for apoptosis [50]. It is noteworthy that the number of 
positive cells against active caspase-3 is not high 
enough to explain the massive necrosis and lymphoid 
depletion that take place in spleen and thymus of 
BTV-infected mice. This is probably because 
Caspase-3 is unable to detect all apoptotic cells [51] , 
and necrosis also occurs in these tissues, likely due to 
the increased oxidative environment. The role of 
active caspase-3 in BTV-induced apoptosis has been 
confirmed in cell lines [47] and in sheep infected with 
BTV-23 where apoptosis in the spleen and peripheral 
blood mononuclear cells (PBMC) and up-regulation of 
caspase-3 mRNA in PBMC were observed [34]. It has 
been suggested that IFN-α could mediate apoptosis 
activating the release of pro-inflamatory cytokines 
and mediating nitric oxide production from activated 
macrophages or endothelial cells [34]. The induction 
of apoptosis in the BTV infected IFNAR(-/-) mice, 
where the IFN-α signaling pathway is blocked, 
indicates that BTV infection could lead to apoptosis in 
an independent IFN-α fashion.  
Ruminants are currently the best animal model 
to study BTV infection. Furthermore, any promising 
vaccine or treatment to be considered for clinical trials 
must be successful in ruminants. However, due to 
ethical, practical, and financial considerations, a 
murine model that reproduces pathological aspects of 
viral infection is a valuable tool to screen potential 
vaccine efficacy and to study BTV transmission, 
pathogenesis and virulence. 
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